$JNJ News and Market Events
Every $JNJ story Market Flux has tracked.
- Market Flux Event
J&J's Tremfya Hits 94% Clinical Remission at Three Years in Crohn's Disease Trial
Johnson & Johnson reported three-year data for Tremfya (guselkumab) in moderately to severely active Crohn's disease, showing sustained clinical and endoscopic remission over the full study…
- Top Mover
Morgan Stanley Hosts Major Healthcare Conference, Expands Bitcoin Holdings Past $609 Million and Downgrades Stellantis
Morgan Stanley's 24th Annual Global Healthcare Conference dominated the firm's activity on September 14, drawing presentations from dozens of companies including Eli Lilly, Pfizer, Johnson…
- Market Flux Event
Dozens of Healthcare and Biotech Companies Showcase Pipelines and Launch Plans at Morgan Stanley, Jefferies and H.C. Wainwright Conferences
September 14, 2026 saw a broad wave of healthcare and biotech presentations across three major investor conferences, with the Morgan Stanley 24th Annual Global Healthcare Conference drawing…
- Market Flux Event
Major Healthcare Conferences Draw Dozens of Companies With Pipeline Updates and Growth Strategies
September 9, 2026 became a showcase day for the healthcare sector as dozens of companies presented across three major investor conferences running simultaneously: the Wells Fargo 21st…
- Market Flux Event
Healthcare Conference Season Peaks With Dozens of Company Presentations as Biotech Names Draw Investor Scrutiny
Dozens of healthcare companies took the stage on September 9 at three major investor gatherings, the Wells Fargo 21st Annual Healthcare Conference, the Cantor Fitzgerald Global Healthcare…
- Unusual Volume
UBS Launches $8 Billion Debt Tender Offer and Issues Broad Wave of Analyst Actions
UBS Group AG launched tender offers to buy back up to $8 billion in its own outstanding debt, the bank's most significant corporate finance move of the day and a signal of balance sheet…
- Market Flux Event
Trump Announces Drug Pricing Deals With Nine More Pharma Companies, Expanding Most Favored Nation Push
President Trump announced on August 31 that his administration has struck drug pricing agreements with nine additional pharmaceutical and biotech companies, committing them to sell…
- Top Mover
Johnson and Johnson Options Activity Surges as Immunology and Neuroscience Units Emerge as Growth Engines
Johnson and Johnson drew notable attention in options markets on Tuesday, with 42,583 contracts trading across its shares, representing approximately 4.3 million underlying shares, among…